Abby-Psyllium
Natural health product licensed in Canada
- Other names
- Abby-Fibre, Abby-Lax, Lax-Relief, Laxative Fibre
- Licence holder
- Abby Pharmaceuticals Corporation
- NPN or DIN-HM
- 80102834
- Status
- Active licence
- Licence date
- 17 July 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 11 years | 1 demi cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adolescentes | minimum: 12 years | 1 demi cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adolescentes | minimum: 13 years ; maximum: 17 years | 1 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
(Used in Herbal Medicine as a) bulk-forming laxative to provide gentle relief of constipation and/or irregularity and promote bowel movements (by increasing bulk volume and water content).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner /health care provider/health care professional/doctor/ physician if symptoms worsen or if laxative effect does not occur within seven days. Consult a health care practitioner/health care provider/health care professional/doctor/ physician immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of other serious conditions).
Source
Official Health Canada record, licence 80102834
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.